$1.86-6.06%
2026-10-06 close · prelimAcrivon Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$89M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Acrivon Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$89M.